← Back to Clinical Trials
Recruiting NCT06951568

NCT06951568 Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06951568
Status Recruiting
Phase
Sponsor Facultat de ciencies de la Salut Universitat Ramon Llull
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-05-02
Primary Completion 2025-07-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Physical Exercise Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-05-02 with a primary completion date of 2025-07-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cerebral palsy (CP) is a permanent neurological disorder that affects movement and posture, caused by an injury to the developing brain. It may also be accompanied by cognitive, hearing, and speech impairments, as well as epilepsy. Although it is a condition that manifests in childhood, its effects persist throughout life, posing specific challenges in mobility and functionality during adulthood. Although physiotherapy is a key component in the rehabilitation of children with CP and helps adults manage pain and improve motor function, many adults with CP do not receive the treatment they need. Barriers such as financial difficulties, transportation issues, and the lack of physiotherapists specialized in CP affect both access to and the quality of care. Even when physiotherapy is provided, adults with CP are often less satisfied with the services compared to children.The aim of this study is to promote the recovery of motor function in adults with cerebral palsy through sensory stimulation of the lower limbs, as part of an intensive motor rehabilitation program. This program seeks to foster autonomy in movements and transfers, as well as active participation in daily life activities.

Eligibility Criteria

Inclusion Criteria * Adults with a medical diagnosis of cerebral palsy * Age: 18-50 years * Reduced mobility classified as levels I, II, or III according to the GMFCS * Ability to participate in functional assessments with the support of the clinical team * Ability to understand informed consent or have a legal representative who can provide consent on their behalf Exclusion Criteria * Patients with cerebral palsy who have severe cognitive impairments that hinder understanding of instructions or participation in assessments * Adults with cerebral palsy who present with medical conditions that may interfere with the intervention, such as severe cardiovascular disease or major neurological disorders * Individuals with cerebral palsy who are participating in another intervention study during the same period

Contact & Investigator

Central Contact

Pedro V López Plaza, Director

✉ pedrovictorlp@gmail.com

📞 932 53 32 56

Frequently Asked Questions

Who can join the NCT06951568 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06951568 currently recruiting?

Yes, NCT06951568 is actively recruiting participants. Contact the research team at pedrovictorlp@gmail.com for enrollment information.

Where is the NCT06951568 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06951568 clinical trial?

NCT06951568 is sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology